Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intercure Ltd (NQ: INCR )

1.243 -0.067 (-5.12%)
Streaming Delayed Price Updated: 3:52 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intercure Ltd

< Previous 1 2 3 Next >
InterCure Shares Soar On FY22 Record Revenue Of $108.3M
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) fiscal year 2022 revenue was NIS 388.7 million ($108.3 million), an increase of 77% compared to NIS 219.7 million in 2021. 
Via Benzinga
Why Eastside Distilling Shares Are Trading Lower By Over 25%; Here Are 20 Stocks Moving Premarket
Gainers Hitek Global Inc. (NASDAQ: HKIT) jumped 25.5% to $6.98 in pre-market trading after gaining 11% on Friday. Hitek Global priced its initial public offering of 3,200,000 ordinary shares at a price... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning! 
Via InvestorPlace
These Companies Team Up To Try To Bring Psilocybin Microdosing Capsules To Australasia
Red Light Holland Corp. (OTCQB: TRUFF) (CSE:TRIP) (FSE:4YX) has signed a distribution agreement with MW Pharma Limited t/a NUBU Pharmaceuticals, to explore the possibility of legal import and... 
Via Benzinga
Israeli Cannabis Producer Touts Record Q3 Revenue, Gross Profit Increase
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, announced on Tuesday its financial and operating results for the third quarter ended September 30, 2022. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 36 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 79 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  OnThursday, 28 stocks made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 35 stocks hit new 52-week lows. 
Via Benzinga
InterCure Sues Cann Pharmaceuticals To Recover Funds Following Failed Merger
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) has filed a lawsuit against Cann Pharmaceuticals Ltd. (dba “Better”), a company with which it had previously sought to merge, to... 
Via Benzinga
InterCure Teams Up Wit Praetorian Global To License, Manufacture And Distribute Cannabis Brand 'Binske'
InterCure Ltd. 
Via Benzinga
InterCure to Participate in Cowen 5th Annual Cannabis Conference
Mr. Rabinovitch is one of the global cannabis senior executives to participate 
From InterCure Ltd.
Via GlobeNewswire
InterCure Announces the Withdrawal of a Class Action Lawsuit against it
From InterCure Ltd.
Via GlobeNewswire
Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower
Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) and Canndoc Ltd., a subsidiary of InterCure Ltd. 
Via Benzinga
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
From Organigram Holdings Inc.
Via Business Wire
InterCure Hits Record Preliminary Q3 Revenue Of $29M
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) released preliminary financial results for the third quarter of 2022, revealing record revenue estimated to be CA$39 million, 63% over the... 
Via Benzinga
InterCure Q2 2022 Revenue Grows 119%, What About Profit?
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) released its financial results for the second quarter of 2022, revealing record revenue of approximately CA$37 million, more than double the... 
Via Benzinga
Clever Leaves 2Q: Neutraceuticals Up, Preparing For Cannabis Flower Exports From Colombia
The Analyst 
Via Benzinga
Israel's Marijuana Bubble Bursts: Tel Aviv Stock Exchange Eliminates TA-Cannabis Index, Ending Three-Year High
It was just three years ago that a broad swath of Israeli society, including former prime ministers, defense bigwigs and celebrities seemed to be enamored by the country's up-and-coming cannabis... 
Via Benzinga
InterCure Reports Record Preliminary Q2 2022 Revenue – More Than Double YoY
InterCure Ltd. 
Via Benzinga
Clever Leaves To Ship First Export Of Cannabis To Israeli Partner InterCure
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) will ship the first commercial export to Israel of high THC flower for medical use from its facility in Portugal through its partnership with... 
Via Benzinga
Cannabis Stocks Struggle Through Q2 2022
An overview of how cannabis stocks fared in Q2 and what investors should understand about the space. 
Via Talk Markets
Invest In The Future Of Medicine Says Berner, CEO Of Cookies At Benzinga's Psychedelics Capital Conference
Berner, the famed rapper, co-founder and CEO of the highly successful cannabis and clothing brand, Cookies, was one of the main speakers at Benzinga's Psychedelics Capital Conference last April at the... 
Via Benzinga
Cannabis Dispensary Roundup: Cookies' CBD Products Now Available In Austria, Parallel & Texas Original Each Open New Stores
Parallel To Open Another Surterra Wellness Store In Florida Parallel is opening a second Surterra Wellness medical marijuana dispensary in Orlando. 
Via Benzinga
InterCure And Berner's Cookies Launch Flagship Retail Location In Vienna, Austria
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) opened the first flagship Cookies store in Austria, located in the Neubau district of Vienna. 
Via Benzinga
InterCure And Berner's Cookies Launch Flagship Cannabis Pharmacy In Be'er Sheva, Israel
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) is opening its flagship Cookies pharmacy in Be'er Sheva, the largest city in Israel's southern region, known as the capital of the Negev. 
Via Benzinga
InterCure Begins 2022 With Record-Breaking Q1 Financial Results, Up 9% Sequentially From Prior Quarter
InterCure (NASDAQ: INCR) released its financial results for the first quarter of 2022 and provided shareholders with a business update. All amounts are expressed in Canadian dollars or New Israeli... 
Via Benzinga
InterCure Reports Record FY 2021 Revenue Of $89M, Q4 Adjusted EBITDA Spikes 140% YoY
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, has announced its estimated financial and operating results for the fourth quarter and year ended December... 
Via Benzinga
Clever Leaves Reports Fourth Quarter And Full Year 2021 Results
Clever Leaves Holdings Inc. (NASDAQ:CLVRW), a leading mul... 
Via Benzinga
InterCure And Clever Leaves Enter Into International Strategic Partnership
InterCure Ltd. (NASDAQ:INCR) (TSX: 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.